NVS

NOVARTIS AG NVS

NYSEMega CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$54.53B

Quarter to Dec 31

Net income

$13.98B

Quarter to Dec 31

Free cash flow

$17.60B

Quarter to Dec 31

Operating margin

32.4%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$21.36B total
Fisher Asset Management, LLC
$2.43B+11.8%
MORGAN STANLEY
$1.37B+2.3%
DIMENSIONAL FUND ADVISORS LP
$1.27B+0.1%
PRIMECAP MANAGEMENT CO/CA/
$1.03B-12.9%
LOOMIS SAYLES & CO L P
$821.10M-3.4%
BANK OF AMERICA CORP /DE/
$769.49M-1.1%
FRANKLIN RESOURCES INC
$509.54M-4.7%
BlackRock, Inc.
$477.68M+3.3%
GOLDMAN SACHS GROUP INC
$467.05M-54.3%
NORTHERN TRUST CORP
$437.68M+0.2%
NATIXIS ADVISORS, LLC
$374.02M+6.7%
ENVESTNET ASSET MANAGEMENT INC
$365.31M+0.8%
JPMORGAN CHASE & CO
$356.85M+25.5%
Jupiter Topco LLC
$348.13M--
GQG Partners LLC
$337.13M-12.1%
FMR LLC
$322.44M+21.5%
Cullen Capital Management, LLC
$318.62M-0.2%
JONES FINANCIAL COMPANIES LLLP
$306.81M+8.4%
WCM INVESTMENT MANAGEMENT, LLC
$300.11M+30.2%
WELLS FARGO & COMPANY/MN
$286.61M-3.5%
RAYMOND JAMES FINANCIAL INC
$282.31M-6.8%
PRINCIPAL FINANCIAL GROUP INC
$245.39M+2.2%
UBS Group AG
$185.62M-33.9%
Holocene Advisors, LP
$162.57MNew
Chevy Chase Trust Holdings, LLC
$162.00M-1.5%
See all 1,634 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NVS

Earnings Per Share

13fpro.ai/company/NVS

Loading ratio trend…

NVS key financials by period

Reported revenue, net income and operating margin by fiscal year, from NOVARTIS AG's annual filings on SEC EDGAR.

NOVARTIS AG reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$54.5B$14.0B32.4%
FY 2024$50.3B$11.9B28.9%
FY 2023$45.4B$14.8B21.5%
FY 2022$42.2B$7.0B18.8%
FY 2021$42.8B$24.0B23.5%
FY 2020$48.7B$8.1B20.9%
Source: NVS filings on SEC EDGAR →

Congress trading in NVS

32 transactions in NVS reported by 11 members of Congress under the STOCK Act, most recent trade Aug 27, 2026. Reported transactions, not recommendations.

All Congress stock trades →

About NOVARTIS AG (NVS): stock profile, AI score and financials

NOVARTIS AG (NVS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NVS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), NOVARTIS AG reports quarterly revenue of $54.5B, net income of $14.0B, an operating margin of 32.4%. Top institutional holders of NVS by reported 13-F value include Fisher Asset Management, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. NVS trades on the NYSE exchange and files with the SEC under CIK 1114448. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NOVARTIS AG directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1114448 →